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Abstract. In this study, we examined the role of the
bumetanide-sensitive Na+/K+/CI- cotransport in the
mitogenic signal of human skin fibroblast prolifera-
tion . The Na+/K+/Cl- cotransport was dramatically
stimulated by either fetal calf serum, or by recom-
binant growth factors, added to quiescent Go/Gt hu-
man skin fibroblasts. The following mitogens, FGF,
PDGF, a-thrombin, insulin-like growth factor-1, trans-
forming growth factor-a, and the phorbol ester, 12-0-
tetradecanoyl-phorbol-13-acetate, all stimulated the
Na+/K+/Cl- cotransport. In addition, all the above
mitogens induced DNA synthesis in the synchronized
human fibroblasts. In order to explore the role of the
Na+/K+/Cl- cotransport in the mitogenic signal, the
effect of two specific inhibitors of the cotransport,
furosemide and bumetanide, was tested on cell
proliferation induced by the above recombinant growth
NE of the earliest responses of quiescent cells to a
mitogenic signal is activation of Na+ influx (Rozen-
gurt, 1986; Rozengurt and Mendoza, 1986). The
bumetanide-sensitive Na+/K+/Cl- cotransport was shown to
be dramatically stimulated by the addition of serum growth
factors to quiescent cells (Tupper et al., 1977; Pallet et al.,
1982, 1983; Panet, 1985; Amsler et al., 1985; Paris and
Pouyssegur, 1986; Panet et al., 1986a, 1989). The question
of whether the Na+/K+/Cl- cotransport has an essential role
in the mitogenic response is still unsolved. Several groups
have observed that inhibition of the Na+/K+/Cl- cotransport
affected only slightly the initiation of DNA synthesis (Owen
and Prastein, 1985 ; Amsler et al., 1985; Paris and Pouys-
segur, 1986) . It has therefore been proposed that the
Na+/K+/Cl- cotransport does not play a major role in the
mitogenic signal (Amsler et al ., 1985 ; Paris and Pouyssegur,
1986). Most ofthese studies, however, were carried out with
immortal rodent cell lines. Nevertheless, the response of
normal diploid human fibroblasts, rather than immortal cell
lines to growth factors, may be different and more relevant
to the normal control of cell proliferation.
Recently, we have investigated the optimal conditions for
thearrest ofhumanskin fibroblasts. Optimal cell density, du-
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factors. Bumetanide and furosemide inhibited syn-
chronized cell proliferation as was measured by (a)
cell exit from the Go/G, phase measured by the use of
flow cytometry, (b) cell entering the S-phase, deter-
mined by DNA synthesis, and (c) cell growth, mea-
sured by counting the cells. The inhibition by furose-
mide and bumetanide was reversible, removal of these
compounds, completely released the cells from the
block of DNA synthesis. In addition, the two drugs
inhibited DNA synthesis only when added within the
first 2-6 h of cell release. These results indicate that
the effect of these drugs is specific, and is not due to
an indirect toxic effect. This study clearly demon-
strates that the growth factor-induced activation of the
Na+/K+/Cl- cotransport plays a major role in the mito-
genic signaling pathway of the human fibroblasts.
ration of serum deprivation, and the serum concentration in
the arrest medium, were analyzed. We have shown that in
cultures of human skin fibroblasts arrested under optimal
conditions, the bumetanide-sensitive Na+/K+/Cl- cotrans-
port is stimulated by two- to threefold after the addition of
fetal calf serum, or purified recombinant growth factors
(Panet and Allan, 1990). In the present study, we analyzed,
with the use of specific inhibitors furosemide and bumeta-
nide, whether stimulation of the Na+/K+/Cl- cotransporter
by serum growth factors is essential for human fibroblast
proliferation. Our results indicate that the growth factors-
induced stimulation of the Na+/K+/Cl- cotransport is an es-
sential part ofthe mitogenic signal of the human fibroblasts.
Materials andMethods
[3H]Thymidine was purchased from the Nuclear Research Centre, Beer-
Sheva, Israel . "Rb+ was purchased from NEN Research Products, Bos-
ton, MA. Bumetanide was kindly provided by Laboratoire Leo, B.P. 28500
Vernouillet, Denmark. Phorbol ester, 12-O-tetradecanoyl-phorbol-13-
acetate (TPA),' propidium iodide, RNAase A, and ouabain were pur-
1. Abbreviations used in this paper: bFGF, basic fibroblast growth factor;
IGF-1, insulin-like growth factor-1; TGFa, transforming growth factor a;
TPA, 12-O-tetradecanoyl-phorbol-13-acetate.
337TableI. Effect ofDifferentMitogenson the
Bumetanide-sensitive Rb+ Influx in Synchronized Cells
Addition
￿
nmol/min/106 cells
- ￿0 .57 t 0.0
FCS (10%)
￿
2.39 t 0.20
PDGF (1 nglml)
￿
1.08 t 0.09
FGF (1 ng/ml)
￿
1.27 t 0.02
TPA (1 ng/ml)
￿
1.34 t 0.12
IGF-1 (l00 nglml)
￿
1.38 t 0.38
TGFa (l00 nglml)
￿
0.87 t 0.07
Cells were seeded in 15-mmdishes (10,000 cells/dish). After 2 d, the cells
were washed andthemedium was replaced with DMEM containing 0.2%FCS
and20 mM Hepes. 2dlater thecells were released by the addition of MEM,
buffered with Hepes-Tris (40 mM, pH 7.0), the indicated mitogens, and
e6Rb+ (5 ACi/ml) in the absence and presence of ouabain (0.5 mM) and
bumetanide (10AM) for6minat 37°C. Bumetanide-sensitive Rb+ influx was
measured and calculated as described in Materials and Methods. Cells were
countedat thetime oftheexperiments by coulter counter, andRb+ fluxes are
expressed per 106 cells.
chased from SigmaChemical Co., St. Louis, MO. Fibroblast growth factor
(bFGF), PDGF, insulin-like growth factor-1 (IGF-1), and transforming
growth factor (x (TGFa),werekindly provided by PeproTech, Inc., Prince-
tonBusiness Park,RockyHill, NJ. a-Thrombin waskindlyprovided by Dr.
R. Bar-Shavit, Department of Oncology, Hadassah University Hospital.
CellCultures
Primary human skin fibroblasts were kindly provided by Dr. S. Yatziv,
Department ofPediatrics, Hadassah University Hospital. Cellswere grown
in DMEM, supplemented with 10% fetal calfserumand4mM glutamine.
This medium was replenished every 2 d. For the arrest of the cell in the
Go/Gt-phase of the cell cycle, the cells were seeded in 10,000/15-mm
dishes. After2dthe cells were washed once,and themedium wasreplaced
with DMEM, supplemented with 0.2% FCS, 4 mM glutamineand 20 mM
Hepes for two more days.
Rb+ Influx Measurements
Bumetanide-sensitive Rb+ influx was measured as reported (Panet et al.,
1982). In brief, Rb+ influx in the presence of ouabain (0.5 mM) and
bumetanide (10 AM) was subtracted from ouabain-resistant Rb+ influx,
andtakenas bumetanide-sensitive Rb+ influx, Each Rb+ influx measure-
ment wasconductedin triplicate cultures andthe results (t SEM) were ex-
pressed for 1116 cells.
DNA Synthesis
Go/G, quiescent cells were released by the addition of FCS (10%) or the
indicated mitogens, introduced directly into thearrest medium in thepres-
ence of [3H]thymidine (0.5 ACi/ml). Allthymidineincorporationmeasure-
ments of this study were performed in the incubator, in the presence of
CO2/HCO3. Trichloroacetic acid-insoluble radioactivity was determined
48 h afterthe release.
Staining theDNA with Propidium Iodide
forFlow Cytofluorometry
Cellstrypsinized andwashed twicewith cold PBS, were suspended in cold
PBS (2 x 106 cells/ml), andfixedby adding slowly, under gentle stirring,
3 ml cold ethanol (95%). The suspension was kept in arefrigerator (4°C)
for further analysis. Before analysis, the cell suspension was centrifuged
(1,000 rpm, 5 min), the pellet was suspendedin PBS (810 141) and RNase
A (10 mg/ml, 90 Al) was added. After 30 min of incubation at 37°C,
propidiumiodide (0.5 mg/ml, 90 Al)wasadded. Thesamples were kept on
iceuntil theanalysis wasconducted. Samples were runin theflow cytome-
terbetween 15 minand3 h after theaddition of propidium iodide. Theflow
cytometry used was FACSTAR Plus (Becton Dickinson & Co., Oxnard,
CA). Thepercentages of cells in the different phases of the mitotic cycle
were calculated using the Cellfit R software (Becton Dickinson & Co.).
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Figure 1. Effect of bumetanide on thymidine incorporation into
DNA induced by of-thrombin. Humanskin fibroblasts were seeded
and serumdeprived for2d, as describedin MaterialsandMethods.
Bumetanide at increasing concentrations was added directly into
the arrest medium in thepresence andabsence of a-thrombin with
[3H]thymidine (0.5 pCi/ml). After 48 h trichloroacetic acid-insol-
uble radioactivity was determined and expressed as cpm/15-mm
plate.
The Bumetanide-sensitive Rb+ Influx
IsStimulatedbyDifferentMitogens in Synchronized
Human Fibroblasts
Addition of FCS to quiescent human fibroblasts resulted in
a dramatic fourfold stimulation of the bumetanide-sensitive
Rb+ influx (Table I) . The following mitogens : PDGF,
bFGF, TPA (all at 1 ng/ml), TGFa, and IGF-1 (both at 100
ng/ml), all stimulated the bumetanide-sensitive Rb+ influx
by about twofold of the control.
Effect ofBumetanide on DNA SynthesisInducedby
a-'Thrombin in theSynchronized Human Fibroblasts
We next examined whether stimulation of the Na+/K+/Cl-
cotransportis essential forthemitogenicsignal. To this end,
we measured the effect ofbumetanide, a specific inhibitorof
the Na+/K+/Cl- cotransport, on synchronized cell entry into
S-phaseinduced by a-thrombin. Humanfibroblasts were ar-
rested by serum deprivation, and a-thrombin was added in
thepresence of differentbumetanide concentrations. Thein-
corporation of [3H]thymidine into trichloroacetic acid-
insoluble material was determined after48 h release in the
presence of C02/HCO3. As seen in Fig. 1, bumetanide in-
hibitedthymidineincorporation inducedby of-thrombin.The
effect ofbumetanide wasdose dependent; at 100 AM concen-
tration it inhibited a noteworthy fraction of thymidineincor-
poration into DNA (50%) induced by a-thrombin (Fig. 1) .
However, thebasal level of thymidine incorporationwas not
affected (Fig. 1). Basedon this result, bumetanide was added
at 100 pM in all the experiments described in this study.
Effect ofBumetanide andFurosemide on CellGrowth
andExitfrom theGo/G,-Phase ofthe Cell Cycle
To analyzewhetherbumetanide does notjust inhibit the Syn-
thesis of DNA, butin fact blocks cell proliferation, we mea-
sured cell replication by direct counting. Quiescent cells,
which were starved for 48 h, were released by the addition
of PDGF (10 ng/ml) or bFGF (1 ng/ml) in the absence or
presence of bumetanide. After 3 d the cells (grown in the
presence of C02/HC03) were trypsinized and counted in a80
60
40
Figure 2. Effect of bumetanide on cell proliferation induced by
PDGF and FGF Quiescent human skin fibroblasts were released
by the addition ofPDGF (10 ng/ml) or FGF (1 ng/ml) in the absence
or presence of bumetanide (100 AM) . After 3 d the cells were
counted by Coulter counter.
Coulter counter. As seen in Fig . 2, bumetanide (100 AM)
added to synchronized human fibroblasts, inhibited cell
growth induced by either PDGF or bFGF. Similar results
were obtained with furosemide (data not shown) .
To directly determine the phase in which furosemide or
bumetanide blocks cell cycle, the methodology of cytofluo-
rometry was applied . As seen in Fig . 3 A, the synchronized
control cells exit the G, and enter the S-phase at 16 h after
serum addition . However, when serum was added in the
presence of furosemide, cell exit from the G,-phase was
much reduced (Fig. 3 B) . At 24 h after serum addition, 60%
of the control cells exit the G,-phase, however, when cells
are released in the presence of furosemide, only 27% of the
cells exit the G,-phase and enter the S-phase (Fig . 3 B) .
Similar results were obtained with bumetanide (data not
shown) .
Since three independent techniques suggested that bu-
metanide and f irosemide block cell cycle, we propose that
the effect is mediated through inhibition of the Na+/K+/Cl-
cotransport .
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Figure 4. Effect offurosemide and bumetanide on thymidine incor-
poration inducedbyPDGF andbFGF Human skin fibroblasts were
seeded and serum deprived for 2 d, as described in Materials and
Methods . The indicated concentrations of PDGF or bFGF were
added directly into the arrest medium with [ 3H]thymidine (0.5
ACi/ml), in the absence or presence of furosemide (FA, 1 mM) or
bumetanide (100 FiM) . After 48 h, trichloroacetic acid-insoluble
radioactivity was determined and expressed as cpm/15-mm plate .
[ 3H]Thymidine incorporation into DNA by the addition of FCS
(10%) was 30,000 f 2,000 cpm/15-mm well .
PDGF and bFGF were found to be potent mitogens ofhu-
man skin fibroblasts (Fig . 4) . Both growth factors, PDGF (10
ng/ml) and bFGF (1 ng/ml) stimulated thymidine incorpora-
tion into DNA to a degree similar to that elicited by FCS
(Fig. 6) . Bumetanide or furosemide inhibited a considerable
fraction of the thymidine incorporation induced by either
PDGF (40-54 %), or bFGF (46-78%) . It appears that at high
concentrations ofbFGF the inhibition ofDNA synthesis by
bumetanide declined . This phenomenon could also be ob-
served with PDGF but to a lesser extent (Fig . 4) . These two
inhibitorsmay either be specific for inhibition ofthe stimula-
tion of the Na+/K+/Cl- cotransport at the early Go/G,-phase,
or theymay exhibit an effect on cellular requirements for the
Na+/K+/Cl- cotransport during the cell cycle . To resolve
this question, we measured the effect of bumetanide when
added to the synchronized cultures at different times after the
release by PDGF As seen in 'Fable II addition ofbumetanide
within the first 2 h ofcell release, inhibited thymidine incor-
20
￿
21 .
Figure 3 Effect of furosemide on the cell cycle of synchronized cells induced by FCS . Human skin fibroblasts were seeded and serum
deprived for 2 d, as described in Materials and Methods . The quiescent cells were released by the addition ofFCS (5%) in the absence
and presence of furosemide (1 mM), which was introduced 15 min before serum was added . At the indicated time cells were harvested,
washed, fixed, and labeled with propidume iodide as described in Materials and Methods . Fluorescence distribution of the cells was mea-
sured using flow cytometer as described in Materials and Methods . In all samples 5,000 nuclei were analyzed by flow cytometry.
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. I ITable11. Effect ofBumetanide Added
at Different Times after PDGF Stimulation on
Thymidine Incorporation into DNA
Quiescent human fibroblasts were released by the addition of PDGF (10 ng/
ml). Bumetanide (100 pM) was added at the indicated time after PDGF addi-
tion. After 48 htrichloroacetic acid-insoluble radioactivity wasdetermined and
expressed as cpm/15-mm plate.
potation into DNA by 45 %, however, when bumetanide was
added 6-12 h after the addition ofPDGF, inhibition ofthymi-
dine incorporation into DNA declined to 12% (')sable II) .
This result supports the proposal that bumetanide specifi-
cally inhibits early events during cell exit from the Go/G,
phase, rather than the cells' requirement for the Na+/K+/Cl-
cotransport during the cell cycle.
Effect ofFurosemide on the Protein Kinase
C-dependent Mitogenic Pathway
As seen in Table I, bumetanide-sensitive Rb+ influx is
stimulated by the phorbol ester TPA. This result indicates the
involvement of protein kinase C in the stimulation of the
Na+/K+/Cl- cotransport in the human fibroblasts. To ana-
lyze whether stimulation of the Na+/K+/Cl- cotransport
through the protein kinase C pathway (Nishizuka, 1984)
plays a role in the mitogenic signal, we measured the conse-
quences of inhibiting this transporter on DNA synthesis in-
duced by TPA. The phorbol ester TPA is a relatively weak
mitogen for human fibroblasts compared with FCS, PDGF,
or bFGF Nevertheless, TPA at 0.1-10 ng/ml stimulated
thymidine incorporation by 4.7-fold (Fig. 5 A) . Furosemide
inhibited 40-50% of thymidine incorporation induced by
TPA, and similar results were achieved by bumetanide (data
not shown). This observation suggests that stimulation ofthe
Na+/K+/Cl- cotransport by protein kinase C-dependent
pathway is involved in this mitogenic pathway.
Effect ofFurosemide on Protein Kinase
C-independent Mitogenic Signal
EGF is mitogenic to human and mouse fibroblasts through
a protein kinase C-independent pathway. In a recent paper
we have demonstrated that the Na+/K+/Cl- cotransport is
stimulated by both a protein kinase C-dependent mechanism
and by the protein kinase C-independent pathway of the
mitogenic signal (Panet and Adan, 1990). To analyze
whether stimulation of the Na+/K+/Cl- cotransport through
the protein kinase C-independent pathways is also involved
in the mitogenic signal, we measured the effect of furose-
mide on DNA synthesis induced by TGFa (Blackshear et al.,
1985; Coughlin et al., 1985; Besterman et al ., 1986) . As
seen in Fig. 5 B, TGFce is mitogenic to these cells, and
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Figure 5. Effect of furosemide on thymidine incorporation induced
by TPAandTGFu. Human skin fibroblasts were seeded andserum
deprived for 2d, as described in Materials andMethods. Theindi-
cated concentration of TPA (A) or TGFa (B) was added directly
into the arrest medium with [3H]thymidine (0.5 ACi/ml), in the
absence or presence off irosemide (FA, 1 mM). After48 h, trichlo-
roacetic acid-insoluble radioactivity was determined and expressed
as cpm/15-mm plate.
furosemide at 1 mM inhibited a large portion (35-55%) of
the mitogenic response to TGFa. This result suggests that
stimulation of the Na+/K+/Cl- cotransport by the protein ki-
nase C-independent pathway is also an essential part for this
mitogenic pathway.
Bumetanide Inhibited DNA Synthesis Induced by FCS
in the Human Fibroblasts
When the synchronized cells were released by FCS (10%),
thymidine incorporation into DNA was inhibited by bumeta-
nide to a smaller extent (in four independent experiments,
29 t 11% inhibition was obtained by bumetanide) than when
the cells were released by the defined mitogens (Figs. 4 and
5). To investigate the reason for the weak effect of bumeta-
nide on thymidine incorporation induced by 10% FCS, we
repeated the experiment but with lower concentrations of
FCS. Quiescenthumanfibroblasts were stimulatedbyincreas-
ing concentrations of FCS, in the absence and presence of
bumetanide. 48 h later, the incorporation of [3H]thymidine
into DNA was determined. As seen in Fig. 6, the extent of
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Figure 6. Effect ofbumetanide and furosemide on thymidine incor-
poration induced by FCS. Human skin fibroblasts were seeded and
serum deprived for 2 d, as described in Materials and Methods.
The indicated concentrations of FCS were added directly into the
arrest medium with [3H]thymidine (0.5 ACi/ml) in the absence or
presence ofbumetanide (100 PM). After 48 h trichloroacetic acid-
insoluble radioactivity was determined and expressed as cpm/15-
mm plate. Thymidine incorporation into DNA at any designated
FCS concentration, was taken as 100%, and the percentage of
DNA synthesis in the presence of bumetanide was calculated and
marked above the suitable bars.
Addition Bumetanide addition time
Thymidine incorporation
cpm Percent
h
- - 3,390 t 870
PDGF - 16,185 f 325 100
PDGF 0 9,125 t 725 56
PDGF 2 10,140 t 285 62
PDGF 6 11,065 f 865 69
PDGF 8 12,845 t 550 80
PDGF 12 14,130 t 175 88Figure 7 . Reversible inhibition of DNA synthesis by
furosemide and bumetanide in synchronized human
skin fibroblasts . Go/G,-phase-arrested human skin
fibroblasts were released by the addition ofPDGF (10
ng/ml), bFGF (1 ng/ml), or IGF-1 (100 ng/ml) in the
absence (open bars) or presence (solid bars) of
furosemide (FA, 1 mM) or bumetanide (bum ., 100
wM) with [3H]thymidine (0.5 jXi/ml) . After 48 h tri-
chloroacetic acid-insoluble radioactivity was deter-
mined and expressed as cpm/15-mm plate. Inparallel,
other cultures were similarly released in the presence of the drugs for 48 h, then washed and fed with fresh medium containing the same
mitogens without the drugs in the presence of ['H]thymidine (0.5 pCi/ml) . After a further 48-h trichloroacetic acid-insoluble radioactiv-
ity was determined and expressed as cpm/15-mm plate (crosshatched bars) . Cultures that were exposed to furosemide or bumetanide in
the absence of any drug in the first part of the experiment were released in the second step by the addition of FCS (10%) . Note thatPDGF
and FGF stimulated thymidine incorporation into DNA to a degree similar to that elicited by FCS .
bumetanide inhibition of thymidine incorporation is depen-
dent on FCS concentrations. It appears'that at high concen-
trations ofFCS, the inhibition ofDNA synthesis by bumeta-
nide declined . This phenomenon might indicate that high
concentrations ofFCS stimulate other transmembrane path-
ways which are not affected by bumetanide.
Reversible Inhibition ofCelt Proliferation
by Furosemide andBumetanide
To test whether inhibition ofDNA synthesis by these com-
pounds is due to a toxic effect, cell cultures which had been
preincubated for 48 h with PDGF, bFGF, or IGF-1, in the
presence of furosemide or bumetanide, were washed and fed
with a fresh medium containing the same mitogens, but
without the inhibitors . 48 h later we measured cell prolifera-
tion by thymidine incorporation into DNA . The inhibition
by furosemide and bumetanide was reversible ; removal of
these compounds completely released the cells from the
block of DNA synthesis (Fig . 7) .
Discussion
The question of whether the Na+/K+/CI- cotransport plays a
role in the mitogenic signal pathway is the subject of this
study. We have demonstrated here, that the Na+/K+/Cl-
cotransport is dramatically stimulated by either fetal calfse-
rum, or by purified recombinant growth factors, added to
quiescent Go/G, human skin fibroblasts. Furthermore, we
have shown that two specific inhibitors of the Na+/K+/Cl-
cotransport, furosemide and bumetanide, inhibited 50-80%
of DNA synthesis induced by the various mitogens. Simi-
larly, the two drugs inhibited cell growth and cell exit from
the Go/G, phase of the cell cycle, induced by the growth
factors . The following mitogens were found to stimulate the
bumetanide-sensitive Na+/K+/Cl- cotransport in quiescent
human fibroblasts : bFGF, PDGF, x--thrombin, IGF-1, TGF-
«, and the phorbol ester TPA . To our knowledge, this is the
first evidence that specific inhibitors of the Na+/K+/Cl-
cotransport block cell proliferation . This study, therefore,
indicates that the growth factor-induced activation of the
Na+/K+/Cl- cotransport plays a major role in the mitogenic
signal pathway. The finding that bumetanide inhibited DNA
synthesis induced by both mitogens which stimulate protein
kinase C (bFGF, PDGF, tx-thrombin ; Blackshear et al .,
1985 ; Coughlin et al ., 1985 ; Besterman et al ., 1986 ; L'Alle-
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main et al., 1986) and those which do not activate protein
kinaseC (TGFce and IGF-1 ; Blackshear et al ., 1985 ; Cough-
lin et al., 1985), implies that stimulation of the Na+/K+ICl-
cotransport has an essential role in the two mitogenic path-
ways . The degree ofcell-cycle inhibition by bumetanide and
furosemide depends on the concentration of the specific
mitogen . This is most distinct withbFGF andFCS (see Figs .
4 and 6) . It seems quite clear that increasing the mitogen
concentrations, overcomes the inhibition by bumetanide or
furosemide. This phenomenon is especially dominated in
cells induced by FCS . This might indicate that high concen-
trations of the mitogen induce other transport systems which
replace the Na+/K+/Cl- cotransport .
The following evidence indicates that the two drugs block
cell exit from the Go/G,-phase of the cell cycle by inhibiting
the Na+/K+/Cl- cotransport . (a) Bumetanide and furosemide
inhibited thymidineincorporation intoDNA onlywhenadded
within the first2-6 h of cell release . (b) In correlation to its
effect on thymidine incorporation, the two drugs inhibited
also cell growth (Fig . 2) and cell exit from the Go/G,-phase,
as measured by flow cytometry (Fig. 3) . (c) The two drugs
reversibly inhibited thymidine incorporation into DNA in-
duced by different mitogens (Figs . I and 4-7) .
The finding that bumetanide and furosemide inhibited
similarly cell proliferation, cell exit from the Go/G,-phase
and thymidine incorporation, excludes the possibility that the
two drugs repress thymidine uptake, rather than thymidine
incorporation intoDNA . Inaddition, it also excludesthe con-
tingency that it slowsdown DNA synthesis rather than block-
ing it . Inhibition of cell proliferation by the two drugs might
exhibit cell requirement for the Na+/K+/Cl- cotransport dur-
ing the cell cycle, rather than specific inhibition of the co-
transport stimulation by the mitogens . The finding that bu-
metanide inhibited thymidine incorporation within the first
hours ofPDGF addition, whereas 8-12 h after the mitogenic
stimulation, theinhibition declined, implies thatthis inhibitor
is specific for a direct mitogen response. The finding that bu-
metanide only slightly inhibited (12% inhibition) thymidine
incorporationwhen added 12 hafterPDGF addition, together
with the finding that the inhibition is reversible, excludes the
possibility that it has a toxic rather than specific effect .
The bumetanide-sensitive Na+/K+/Cl- cotransport was
reported to be dramatically stimulated by serum growth fac-
tors in immortal cell lines such as 3T3 mouse cells, or in
hamster fibroblasts (Tupper et al ., 1977; Panet et al ., 1982,
1983 ; Panet, 1985 ; Amsler et al ., 1985 ; Paris and Pouys-
34 1segur,1986; Panetet al., 1986a,b, 1989) . On the other hand,
one report has suggested that this transporter is only slightly
stimulated in human diploid fibroblasts (Owen and Prastein,
1985). Recently we have established optimal conditions for
arresting human skin fibroblasts at the Go/G,-phase of the
cell cycle (Panet and Atlan, 1990). Under these conditions,
the Na+/K+/Cl- cotransport is two- to threefold stimulated
by either fetalcalfserum or purified recombinant growth fac-
tors. The observation that this transporter in human fibro-
blasts was only slightly stimulated by growth factors (Owen
and Prastein, 1985) could be due to the insufficient period
of serum starvation (4 h).
In summary, we have shown that bumetanide or furose-
mide, added to quiescent human skin fibroblasts, inhibited
50-80% of cell proliferation induced by different mitogens.
This study demonstrates that the growth factor stimulation
of the Na+/K+/Cl- cotransport plays an essential role in the
mitogenic signal of the human fibroblasts.
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